Hemoteq is a leading specialist in the market for biocompatible and drug eluting surfaces. The company develops ultrathin functional coatings and surface modification solutions for medical devices, supports its customers with comprehensive services to obtain regulatory approval and provides high level clean room capacities for volume production. The application focus is on cardiology, ophthalmology, orthopedics and dentistry. Hemoteq has a large customer base including leading European, North American and Asian medical device manufacturers.

PINOVA acquired the stake of an existing shareholder in April 2010 and will support further international growth of the company.